Mitral stenosis is a condition characterized by narrowing of the mitral valve of the heart, which leads to disruption of normal blood flow between the left atrium and the left ventricle. This condition is most often observed as a result of rheumatic heart disease, which can develop after acute infections such as rheumatic fever. The main symptoms of mitral stenosis are shortness of breath, especially during physical activity, fatigue, swelling of the extremities, and pre-syncope. Over time, if not treated adequately, the patient's condition can significantly worsen, which can lead to serious complications, including heart failure and arrhythmia.
History of the disease and interesting historical facts
The history of mitral stenosis has deep roots, going back to the beginning of scientific medicine. The first descriptions of heart disease date back to the 16th century, but detailed study of the mitral valve began only in the 19th century. In 1829, the French physician Gabriel Gregory Dupuy first described the anatomical changes associated with mitral stenosis. In 1906, the term "mitral stenosis" was proposed, which became generally accepted to refer to this condition. Interestingly, before the advent of antibiotics, rheumatic fever was one of the main causes of mitral stenosis, making this pathology quite common in adolescence. With the development of medical science and the emergence of new treatment methods, such as endovascular interventions, there is a tendency to reduce the prevalence of this disease.
Epidemiology
Mitral stenosis is relatively rare compared to other cardiovascular diseases. According to the latest statistics, the incidence of mitral stenosis is about 0.5-2% of the total number of cases of cardiovascular diseases. Rheumatic mitral stenosis is more common in countries with poor health care, where the incidence of acute infections leading to rheumatic fever is high. In developed countries, the main risk factor is the aging of the population, which is associated with degenerative changes in the valvular apparatus of the heart. Thus, age-related mitral stenosis is observed in 15-20% patients over 70 years of age.
Genetic predisposition to this disease
Although mitral stenosis is most often the result of rheumatic heart disease, some cases may have a genetic predisposition. Research shows that certain genetic mutations may increase the risk of developing valve disease. Key genes associated with the development of mitral stenosis are GDF15 and MMP2. Mutations in these genes can lead to degenerative changes in the structures of the mitral valve and its functional insufficiency. However, it should be noted that the presence of these mutations does not guarantee the development of the disease, since its occurrence is influenced by many factors, including the environment and individual medical history.
Risk factors for the development of this disease
Among the key risk factors for the development of mitral stenosis are:
- Rheumatic fever is the most common cause of mitral stenosis, occurring after a streptococcal infection;
- Age - the disease is more common in older people, which is associated with age-related changes in the cardiovascular system;
- Presence of chronic heart disease - conditions such as coronary artery disease can contribute to the development of stenosis;
- Family history of heart disease - a predisposition to cardiovascular disease may be hereditary;
- Obesity and a sedentary lifestyle increase the risk of cardiovascular diseases, including mitral stenosis;
Diagnosis of this disease
Diagnosis of mitral stenosis involves both clinical evaluation and the use of various diagnostic methods. The main symptoms to look for include shortness of breath, especially with physical activity, fatigue, swelling of the extremities, and cough.
Laboratory tests may include a complete blood count, hemoglobin levels, and other markers that indicate heart failure. Radiological examinations such as chest X-rays and echocardiography play a key role in visualizing the condition of cardiac structures. Echocardiography can determine the degree of stenosis, its anatomical features, and functional characteristics.
Differential diagnosis includes ruling out other conditions such as aortic stenosis and myocardial disease, which may have similar symptoms.
Treatment
Treatment of mitral stenosis is aimed at improving the patient's quality of life and preventing complications. Pharmacological treatment includes the use of diuretics to reduce swelling, antiarrhythmic drugs to correct the heart rhythm, and drugs that improve cardiac function, such as ACE inhibitors.
Surgical treatment is the mainstay for patients with severe stenosis and includes valvuloplasty or mitral valve replacement. Endovascular techniques such as mitral balloon valvuloplasty are becoming increasingly popular, allowing for a significantly less invasive procedure.
Other treatments may include supportive care and rehabilitation aimed at restoring the patient's physical activity after the procedure.
List of medications used to treat this disease
- Diuretics (furosemide, hydrochlorothiazide);
- Antiarrhythmic drugs (amidarone, propafenone);
- ACE inhibitors (enalapril, lisinopril);
- Beta blockers (metoprolol, bisoprolol);
- Blood thinners (warfarin, rivaroxaban);
Disease monitoring
Monitoring of patients with mitral stenosis involves regular observation of their condition and assessment of the effectiveness of treatment. Control stages may include echocardiography to assess the dynamics of valve narrowing and heart function. The prognosis depends on the degree of stenosis and the presence of concomitant diseases. Possible complications include heart failure, arrhythmia, and the risk of stroke due to thrombus formation.
Age-related features of the disease
Mitral stenosis can manifest itself differently depending on the age group. In young people, the disease is more often associated with rheumatic fever and has an acute onset, while in older people it can develop gradually and manifest as chronic shortness of breath and heart failure. It is also worth noting that in older patients, the possibility of surgical intervention may be limited by concomitant diseases and the general condition of the heart.
Questions and Answers
- What are the main symptoms of mitral stenosis? The main symptoms include shortness of breath, fatigue, swelling of the extremities, cough and lightheadedness.
- How is mitral stenosis diagnosed? Diagnosis includes clinical evaluation, echocardiography, radiography and laboratory tests.
- What is the main treatment for mitral stenosis? Treatment may be medical or surgical, including diuretics, antiarrhythmic drugs, and surgical valve replacement.
- What are the risk factors for developing this disease? Major risk factors include rheumatic fever, age, chronic heart disease and physical inactivity.
- What are the possible complications of mitral stenosis? Possible complications include heart failure, thrombosis and arrhythmias, which require constant patient monitoring.
